292 related articles for article (PubMed ID: 16446331)
21. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival.
Obermair A; Manolitsas TP; Leung Y; Hammond IG; McCartney AJ
Gynecol Oncol; 2004 Mar; 92(3):789-93. PubMed ID: 14984942
[TBL] [Abstract][Full Text] [Related]
22. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
23. Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study.
Malzoni M; Tinelli R; Cosentino F; Perone C; Rasile M; Iuzzolino D; Malzoni C; Reich H
Gynecol Oncol; 2009 Jan; 112(1):126-33. PubMed ID: 18947861
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome.
Kalogiannidis I; Lambrechts S; Amant F; Neven P; Van Gorp T; Vergote I
Am J Obstet Gynecol; 2007 Mar; 196(3):248.e1-8. PubMed ID: 17346541
[TBL] [Abstract][Full Text] [Related]
25. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
[TBL] [Abstract][Full Text] [Related]
26. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
[TBL] [Abstract][Full Text] [Related]
27. Endometrial cancer in premenopausal women 45 years and younger.
Gitsch G; Hanzal E; Jensen D; Hacker NF
Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
[TBL] [Abstract][Full Text] [Related]
28. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
32. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
Wang HY; Shen L; Sun Z
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
[TBL] [Abstract][Full Text] [Related]
33. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
[TBL] [Abstract][Full Text] [Related]
34. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
35. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy.
Fanning J
Gynecol Oncol; 2001 Aug; 82(2):371-4. PubMed ID: 11531297
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study.
Sovak MA; Hensley ML; Dupont J; Ishill N; Alektiar KM; Abu-Rustum N; Barakat R; Chi DS; Sabbatini P; Spriggs DR; Aghajanian C
Gynecol Oncol; 2006 Nov; 103(2):451-7. PubMed ID: 16677690
[TBL] [Abstract][Full Text] [Related]
37. Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.
Chan JK; Lin YG; Monk BJ; Tewari K; Bloss JD; Berman ML
Obstet Gynecol; 2001 May; 97(5 Pt 1):707-11. PubMed ID: 11339920
[TBL] [Abstract][Full Text] [Related]
38. Estrogen replacement therapy in breast cancer survivors: a matched-controlled series.
Decker DA; Pettinga JE; VanderVelde N; Huang RR; Kestin L; Burdakin JH
Menopause; 2003; 10(4):277-85. PubMed ID: 12851510
[TBL] [Abstract][Full Text] [Related]
39. Survival after multimodality treatment for stage IIIC endometrial cancer.
Katz LA; Andrews SJ; Fanning J
Am J Obstet Gynecol; 2001 May; 184(6):1071-3. PubMed ID: 11349160
[TBL] [Abstract][Full Text] [Related]
40. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
Solhjem MC; Petersen IA; Haddock MG
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
